---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-269493"
form_type: "8-K"
ticker: "WHWK"
cik: "0001422142"
company_name: "Whitehawk Therapeutics, Inc."
filed_at: "2026-06-12T20:19:09+00:00"
generated_at: "2026-06-12T20:39:04.119583+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Whitehawk Therapeutics shareholders elect three Class III directors at annual meeting

## Summary
- Behzad Aghazadeh, Richard Maroun, and Emma Reeve elected as Class III directors with 26.7M, 27.7M, and 27.7M votes for, respectively.
- Advisory say-on-pay passed with 22.9M for, 6.0M against, 3.6M abstain.
- Ratification of BDO USA as auditor for FY 2026 passed with 34.8M for, 1.1M against, 4.4M abstain.
- Approximately 82% of voting power (40.4M shares) present, constituting a quorum.

## SEC filing metadata
- accession: 0001193125-26-269493
- form_type: 8-K
- ticker: WHWK
- cik: 0001422142
- company_name: Whitehawk Therapeutics, Inc.
- filed_at: 2026-06-12T20:19:09+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/0001193125-26-269493-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/whwk-20260611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-269493
- JSON: https://secwatch.observer/filing/0001193125-26-269493.json
- Plain text: https://secwatch.observer/filing/0001193125-26-269493.txt

## Key facts
- Shareholder Votes
  Whitehawk Therapeutics, Inc. shareholders approved Election of three Class III directors at the 2026-06-11 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-11
  source text: Behzad Aghazadeh, Ph.D. 26,666,124 5,867,225 7,841,674 Richard Maroun 27,701,332 4,832,017 7,841,674 Emma Reeve 27,704,564 4,828,785 7,841,674
  evidence_url: https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/0001193125-26-269493-index.htm
- Shareholder Votes
  Whitehawk Therapeutics, Inc. shareholders approved Ratification of BDO USA, P.C. as independent registered public accounting firm at the 2026-06-11 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-11
  source text: Ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstentions 34,795,850 1,148,282 4,430,891
  evidence_url: https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/0001193125-26-269493-index.htm
- Shareholder Votes
  Whitehawk Therapeutics, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-11 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-11
  source text: Proposal 2: To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the “Executive Compensation” section of the Proxy Statement. For Against Abstentions Broker Non-Votes 22,896,061 6,013,600 3,623,688 7,841,674
  evidence_url: https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/0001193125-26-269493-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.